Lanean...
AT-01 PHASE I TRIAL OF DOSE ESCALATED RADIOSURGERY PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
BACKGROUND: Management of recurrent glioblastoma (rGBM) after standard initial therapy remains one of the most difficult challenges in oncology. Prior use of salvage stereotactic radiosurgery (SRS) for rGBM often involved maximum prescription doses defined by RTOG 90-05. We performed a prospective P...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217786/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|